S., Ugel, S., Tsirigos, A., Bronte, V., Munn, D
Food and Drug Administration Certain Bulk Drug Substances page lists Selank acetate (TP-7) in the withdrawn nominators table, with the following verbatim safety concern: Compounded drugs containing selank acetate may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities
In formal pharmacokinetic studies in rats following intravenous administration, BPC-157 has a mean elimination half-life of approximately 15.2 minutes, with the peptide becoming undetectable within 4 hours
Addresses fatigue, one of the most common complaints of modern living
High blood pressure or migraine: High blood pressure and migraine have both been linked to tinnitus, although the exact relationship isnt always clear